tag:anvisa.feeds.abelhaninja.de,2026:feeds:cmed/substancia/luspatercepte2026-10-22T15:48:56.207578-03:00anvisa-feedsanvisa-feeds (dados: CMED/ANVISA)tag:anvisa.feeds.abelhaninja.de,2026:feeds:cmed/substancia/luspatercepte/202610092026-10-22T15:48:56.207578-03:00<p>sem mudanças</p><table class="queue" id="rows"><caption>Lista atual (4 apresentações)</caption><thead><tr><th>Produto</th><th>Apresentação</th><th>Laboratório</th><th>PF 0 %</th><th>PMC 0 %</th><th>PMVG 0 %</th><th class="d">Regime</th></tr></thead><tbody><tr title="GGREM 505122030021901"><td>REBLOZYL</td><td>25 MG PO LIOF SOL INJ SC CT FA VD TRANS</td><td>BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA</td><td class="p">R$ 12.841,00</td><td class="p">–</td><td class="p">R$ 10.299,77</td><td class="d">Regulado</td></tr><tr title="GGREM 505122030022001"><td>REBLOZYL</td><td>75 MG PO LIOF SOL INJ SC CT FA VD TRANS</td><td>BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA</td><td class="p">R$ 38.518,67</td><td class="p">–</td><td class="p">R$ 30.895,83</td><td class="d">Regulado</td></tr><tr title="GGREM 505124060024607"><td>ROJUZDA</td><td>25 MG PO LIOF SOL INJ SC CT FA VD TRANS</td><td>BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA</td><td class="p">R$ 12.840,99</td><td class="p">–</td><td class="p">R$ 10.299,76</td><td class="d">Regulado</td></tr><tr title="GGREM 505124060024707"><td>ROJUZDA</td><td>75 MG PO LIOF SOL INJ SC CT FA VD TRANS</td><td>BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA</td><td class="p">R$ 38.518,66</td><td class="p">–</td><td class="p">R$ 30.895,82</td><td class="d">Regulado</td></tr></tbody></table>